Medicis Pharmaceutical has sued Perrigo for patent infringement regarding the product.
Perrigo Company (Nasdaq:PRGO; TASE:PRGO) has filed an Abbreviated New Drug Application (ANDA) with the US Food and Drug Administration (FDA) for Fluocinonide Cream 0.1%, a generic version of Vanos Cream 0.1%. The company believes that it is the first to file an ANDA with a Paragraph IV certification for the product. Brand Vanos is made by Medicis Pharmaceutical Corporation (NYSE: MRX).
Vanos is a corticosteroid (steroid hormone) approved to relieve the inflammation and itching caused by certain skin conditions that respond to treatment with corticosteroids in patients 12 years of age or older. According to Wolters Kluwer Health, it had $27 million in sales in the 12 months ended April 2008.
On June 6, 2008, Medicis filed suit alleging patent infringement in the US District Court for the Western District of Michigan to prevent Perrigo from proceeding with the commercialization of its product. This action formally initiates the patent process under the Hatch-Waxman Act.
Published by Globes [online], Israel business news - www.globes-online.com - on June 10, 2008
© Copyright of Globes Publisher Itonut (1983) Ltd. 2008